Michael Dershem
CEO
Apierion

Michael Dershem, aka Dersh, is a seasoned business development entrepreneur primarily in the healthcare and pharma space, who has assisted multiple ventures and attracted millions of dollars of capital. Michael began his ‘serial entrepreneur’ career over twenty years ago. His first foray was as co-owner of RX Returns, the first reverse distributor ever licensed by the FDA and DEA, which grew to become the largest pharmaceutical returns company in the nation. He later helped form a niche banking company, which became one of the fastest growing private companies in New Jersey. Serving as founding CEO of Pharmasset, an Emory University start-up company, successfully raised over $25 million in private equity funding and executed a $30 million research and development agreement with DuPont. The company has subsequently gone public and was acquired by Gilead Sciences for $11 Billion, and has led to the eradication of Hep C.